247 related articles for article (PubMed ID: 7492625)
1. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution.
Schwella N; Siegert W; Beyer J; Rick O; Zingsem J; Eckstein R; Serke S; Huhn D
Ann Hematol; 1995 Nov; 71(5):227-34. PubMed ID: 7492625
[TBL] [Abstract][Full Text] [Related]
2. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.
Schwella N; Beyer J; Schwaner I; Heuft HG; Rick O; Huhn D; Serke S; Siegert W
J Clin Oncol; 1996 Apr; 14(4):1114-21. PubMed ID: 8648365
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
4. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation.
Heuft HG; Dubiel M; Kingreen D; Oertel J; De Reys S; Rick O; Serke S; Schwella N
Vox Sang; 2000; 79(2):94-9. PubMed ID: 11054047
[TBL] [Abstract][Full Text] [Related]
5. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in patients with lymphoma, myeloma and solid tumors.
Efremidis AP; Koumakis G; Filis J; Moraki M; Vassilomanolakis M; Hatzichristou H; Barbounis V; Stamatellou M; Papanastasiou K; Kritsioti M; Plataniotis G; Arseni P
Eur J Haematol; 1996 Oct; 57(4):269-77. PubMed ID: 8982289
[TBL] [Abstract][Full Text] [Related]
7. Associations among white blood cells, CD34+ cells and GM-CFU in predicting the optimal timing of peripheral blood stem cell collections by apheresis.
Boulassel MR
J Assoc Physicians India; 2008 Feb; 56():96-8. PubMed ID: 18472508
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
9. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
Smith RJ; Sweetenham JW
Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
[TBL] [Abstract][Full Text] [Related]
10. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Tarella C; Di Nicola M; Caracciolo D; Zallio F; Cuttica A; Omedè P; Bondesan P; Magni M; Matteucci P; Gallamini A; Pileri A; Gianni AM
Bone Marrow Transplant; 2002 Dec; 30(11):725-32. PubMed ID: 12439694
[TBL] [Abstract][Full Text] [Related]
11. The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.
Benjamin RJ; Linsley L; Axelrod JD; Churchill WH; Sieff C; Shulman LN; Elias A; Ayash L; Malachowski ME; Uhl L
Transfusion; 1995 Oct; 35(10):837-44. PubMed ID: 7570914
[TBL] [Abstract][Full Text] [Related]
12. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
Faucher C; Le Corroller AG; Chabannon C; Viens P; Stoppa AM; Bouabdallah R; Camerlo J; Vey N; Gravis G; Gastaut JA; Novakovitch G; Mannoni P; Bardou VJ; Moatti JP; Maraninchi D; Blaise D
J Hematother; 1996 Dec; 5(6):663-70. PubMed ID: 9117255
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
[TBL] [Abstract][Full Text] [Related]
14. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
15. Plastic-adherent progenitor cells in mobilized peripheral blood progenitor cell collections.
Scott MA; Apperley JF; Jestice HK; Bloxham DM; Marcus RE; Gordon MY
Blood; 1995 Dec; 86(12):4468-73. PubMed ID: 8541535
[TBL] [Abstract][Full Text] [Related]
16. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.
Moncada V; Bolan C; Yau YY; Leitman SF
Transfusion; 2003 Apr; 43(4):495-501. PubMed ID: 12662283
[TBL] [Abstract][Full Text] [Related]
18. Leukapheresis after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft.
Schwella N; Braun A; Ahrens N; Rick O; Salama A
Transfusion; 2003 Feb; 43(2):259-64. PubMed ID: 12559023
[TBL] [Abstract][Full Text] [Related]
19. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children.
Leibundgut K; von Rohr A; Brülhart K; Hirt A; Ischi E; Jeanneret C; Muff J; Ridolfi-Lüthy A; Wagner HP; Tobler A
Bone Marrow Transplant; 1995 Jan; 15(1):25-31. PubMed ID: 7538000
[TBL] [Abstract][Full Text] [Related]
20. Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses.
Dobo I; Robillard N; Pineau D; Geneviève F; Piard N; Rapp MJ; Boasson M; Zandecki M; Hermouet S
Ann Hematol; 2001 Nov; 80(11):639-46. PubMed ID: 11757722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]